Regents of the University of California’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Regents of the University of California’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$1.6M	Buy	34,925 +17,356	+99%	+$519K	1.83%	16
2013 Q2	$475K	Buy	+17,569	New	+$402K	0.26%	57

Other funds holding KYTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Regents of the University of California's KYTH Position: Q3 2013 in Review

Regents of the University of California increased its KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) stake by 99% in Q3 2013, buying an estimated $519K and bringing the position to 34,925 shares worth $1.6M. The position accounts for 1.83% of the portfolio, ranked #16.

Regents of the University of California first reported a position in KYTH in Q2 2013 and has held it in 2 quarters since. 83 funds tracked by Wall St. Rank hold KYTH as of Q3 2013.

Regents of the University of California held 34,925 shares of KYTHERA BIOPHARMACEUTICALS, INC COM worth $1.6M as of Q3 2013.
Regents of the University of California bought 17,356 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2013, an estimated $519K.
KYTHERA BIOPHARMACEUTICALS, INC COM made up 1.83% of Regents of the University of California's portfolio in Q3 2013, its #16 holding.
Regents of the University of California first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and has held it in 2 quarters since.
83 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2013.

Based on Regents of the University of California's 13F filing for Q3 2013, filed 28 Oct 2013.